Navigate the critical balance of M&A, affordability, and alternative funding pathways shaping our global healthcare’s future — Imagine a global chess match, where each move determines the trajectory of our healthcare system. On the chessboard are large pharmaceutical organizations, considered the vanguards of medical innovation, and the Federal Trade Commission (FTC). Their moves shape the intricate dynamics of the industry.
